|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee (A.B., J.L., A.M.D.); and Department of Anesthesiology, University of California Los Angeles, Los Angeles, California (L.T.)
Among the nongenomic effects of steroids, control of vasomotion has received increasing attention. Lithocholate (LC) and other physiologically relevant cholane-derived steroids cause vasodilation, yet the molecular targets and mechanisms underlying this action remain largely unknown. We demonstrate that LC (45 µM) reversibly increases the diameter of pressurized resistance cerebral arteries by
10%, which would result in
30% increase in cerebral blood flow. LC action is independent of endothelial integrity, prevented by 55 nM iberiotoxin, and unmodified by 0.8 mM 4-aminopyridine, indicating that LC causes vasodilation via myocyte BK channels. Indeed, LC activates BK channels in isolated myocytes through a destabilization of channel long-closed states without modifying unitary conductance. LC channel activation occurs within a wide voltage range and at Ca2+ concentrations reached in the myocyte at rest and during contraction. Channel accessory β1 subunits, which are predominant in smooth muscle, are necessary for LC to modify channel activity. In contrast, β4 subunits, which are predominant in neuronal tissues, fail to evoke LC sensitivity. LC activation of cbv1+β1 and native BK channels display identical characteristics, including EC50 (46 µM) and Emax (
300 µM) values, strongly suggesting that the cbv1+β1 complex is necessary and sufficient to evoke LC action. Finally, intact arteries from β1 subunit knockout mice fail to relax in response to LC, although they are able to respond to other vasodilators. This study pinpoints the BK β1 subunit as the molecule that senses LC, which results in myocyte BK channel activation and, thus, endothelial-independent relaxation of small, resistance-size arteries.
Address correspondence to: Dr. Alex Dopico, University of Tennessee Health Science Center, Department of Pharmacology, 874 Union Ave. Memphis, TN 38163. E-mail: adopico{at}utmem.edu
This article has been cited by other articles:
![]() |
M. Tong and R. K. Duncan Tamoxifen inhibits BK channels in chick cochlea without alterations in voltage-dependent activation Am J Physiol Cell Physiol, July 1, 2009; 297(1): C75 - C85. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hou, S. H. Heinemann, and T. Hoshi Modulation of BKCa Channel Gating by Endogenous Signaling Molecules Physiology, February 1, 2009; 24(1): 26 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Bukiya, J. McMillan, A. L. Parrill, and A. M. Dopico Structural determinants of monohydroxylated bile acids to activate {beta}1 subunit-containing BK channels J. Lipid Res., November 1, 2008; 49(11): 2441 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, T. Vaithianathan, K. Manivannan, A. Parrill, and A. M. Dopico Ethanol Modulates BKCa Channels by Acting as an Adjuvant of Calcium Mol. Pharmacol., September 1, 2008; 74(3): 628 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vaithianathan, A. Bukiya, J. Liu, P. Liu, M. Asuncion-Chin, Z. Fan, and A. Dopico Direct Regulation of BK Channels by Phosphatidylinositol 4,5-Bisphosphate as a Novel Signaling Pathway J. Gen. Physiol., July 1, 2008; 132(1): 13 - 28. [Abstract] [Full Text] [PDF] |
||||